Based on the transcript of the UnitedHealth Group's second quarter 2017 earnings call, here are the key points that could influence the short-term impact on the stock price:

- **Strong Financial Performance**: UnitedHealth Group reported strong and balanced revenue growth, with adjusted net earnings growing 26% year-over-year to $2.46 per share. This robust financial performance is likely to be positively received by investors[3|.
- **Growth Momentum**: The company demonstrated significant growth across its businesses, including UnitedHealthcare and Optum, with a strong pipeline and backlog indications. This momentum suggests continued organic growth and market expansion[3|.
- **Positive Outlook**: Management expressed optimism about future growth, particularly in Medicare Advantage and OptumCare, and anticipated continued performance improvement in 2018. This positive outlook can boost investor confidence[3|.
- **Operational Efficiency**: The company highlighted well-contained operating costs and strong cash flows, which are positive indicators of its financial health and operational efficiency[3|.
- **Market Positioning**: UnitedHealth Group's focus on innovation, quality, and customer satisfaction, as well as its expanding relationships with care providers and strategic partnerships, positions the company well for future growth and market share gains[3|.
- **External Factors**: While there are external headwinds such as national and state healthcare policies and potential tax changes, the company's diversified portfolio and strong leadership team are expected to help navigate these challenges[3!.

Given these points, the overall tone of the call is positive, indicating strong performance, growth momentum, and a optimistic outlook.

**Rating: 2**